| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AMERICAN FUNDS CAP INCOME BUIL | 176,819 | 228,516 |
| AMERICAN GROWTH FD OF AMERICA | 182,165 | 365,058 |
| ATRICURE, INC. | 40,541 | 618,121 |
| CAPITAL WORLD GROWTH & INC | 183,044 | 320,143 |
| PROSHARES TRUST | 1,232,460 | 990,001 |
| SIRTEX MEDICAL | 50,674 | 104,610 |
| XENOPORT, INC. | 8,006 | 4,583 |
| Category/ Item | Cost/Other Basis | Accumulated Depreciation | Book Value | End of Year Fair Market Value |
|---|
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ENABLE INJECTIONS, LLC | 210,402 | 432,407 | |
| ENABLE UROLOGY, LLC | 76,703 | 4,000 | |
| LITHOS MEDICAL CONV NOTE - 50K | 50,000 | 50,000 | |
| LITHOS MEDICAL CONV NOTE - 75K | 75,000 | 75,000 | |
| NEURONETICS, INC. SER. D PFD | 125,000 | 102,459 | |
| NEURONETICS, INC. SER. E PFD | 300,000 | 300,000 | |
| PRECEPTIS MEDICAL, INC. CONVER | 250,000 | 250,000 | |
| SALEM ZS INVESTORS LLC | 250,000 | 250,000 | |
| SKYLINE VENTURE PARTNERS III, | 35,152 | ||
| SKYLINE VENTURE QUALIFIED PURC | 40,054 | 6,469 | |
| SUREFIRE MEDICAL SERIES B-1 PR | 1,000,000 | 999,999 | |
| SUREFIRE MEDICAL SERIES B-2 PR | 1,500,001 | 1,500,001 | |
| SUREFIRE SERIES A PREFERRED ST | 805,000 | 107,881 | |
| USVP ENTREPRENEUR PARTNERS VII | 59,253 | 51,531 | |
| ZS PHARMA, INC. SER. A PFD | 100,000 | 125,000 | |
| ZUREX PHARMA, INC SERIES A PRE | 200,000 | 95,658 |
| Category / Item | Cost / Other Basis | Accumulated Depreciation | Book Value | End of Year Fair Market Value |
|---|
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative Fees | 31,546 | 31,546 | ||
| K-1 Exp SKYLINE VENTURE PARTNE | 147 | 147 | ||
| K-1 Exp SKYLINE VENTURE QUALIF | 48 | 48 | ||
| K-1 Exp USVP ENTREPRENEUR PART | 1,768 | 1,768 | ||
| Office Supplies | 135 | 135 | ||
| State or Local Filing Fees | 61 | 61 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| K-1 Inc/Loss ENABLE INJECTIONS, LLC | -93,490 | -93,490 | |
| K-1 Inc/Loss ENABLE UROLOGY, LLC | -1,812 | -1,812 | |
| K-1 Inc/Loss SKYLINE VENTURE PARTNERS III, L.P. | 1 | 1 | |
| K-1 Inc/Loss USVP ENTREPRENEUR PARTNERS VIII-B, LP | 43 | 43 |
| Name of 501(c)(3) Organization | Balance Due |
|---|---|
|
COMMUNICATION SCIENCE INC LOAN REC |
50,000 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PHILANTHROPIC CONSULTING FEES | 12,000 | 12,000 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF Estimated Tax for 2013 | 9,900 |